How desirable and undesirable features of naϊve or genetically reengineered mesenchymal stem cells are being considered in preclinical or clinical assays

Carlos Alberto González Villarreal; Herminia G. Martínez-Rodríguez; Salvador Said-Fernández

How desirable and undesirable features of naϊve or genetically reengineered mesenchymal stem cells are being considered in preclinical or clinical assays

Carlos Alberto González Villarreal, Herminia G. Martínez-Rodríguez, Salvador Said-Fernández

Producción científica › revisión exhaustiva

Idioma original	English
Publicación	Journal of B.U.ON.
Estado	Published - 2017

Acceder al documento

https://www.ncbi.nlm.nih.gov/pubmed/29155506Licencia: Unspecified

Citar esto

@article{3517739dfa44456faa8ce4140bd324c7,

title = "How desirable and undesirable features of naϊve or genetically reengineered mesenchymal stem cells are being considered in preclinical or clinical assays",

author = "{Gonz{\'a}lez Villarreal}, {Carlos Alberto} and Mart{\'i}nez-Rodr{\'i}guez, {Herminia G.} and Salvador Said-Fern{\'a}ndez",

year = "2017",

language = "English",

journal = "Journal of B.U.ON.",

issn = "1107-0625",

publisher = "Zerbinis Publications",

}

TY - JOUR

T1 - How desirable and undesirable features of naϊve or genetically reengineered mesenchymal stem cells are being considered in preclinical or clinical assays

AU - González Villarreal, Carlos Alberto

AU - Martínez-Rodríguez, Herminia G.

AU - Said-Fernández, Salvador

PY - 2017

Y1 - 2017

M3 - Article

SN - 1107-0625

JO - Journal of B.U.ON.

JF - Journal of B.U.ON.

ER -